Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E

Detalhes bibliográficos
Autor(a) principal: Gonçalves, Elisabete
Data de Publicação: 1998
Outros Autores: Almeida, Leonor M., Dinis, Teresa C. P.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/5823
https://doi.org/10.1016/S0378-5173(98)00211-7
Resumo: It is now recognized that the antioxidant defences in the colonic mucosa from patients with inflammatory bowel disease (IBD) are particularly low. On account of this we studied the antioxidant capacity of 5-ASA, the first choice therapy in this pathological situation, in combination with the endogenous antioxidants vitamins C (ASC) and E ([alpha]-tocopherol ([alpha]-T)) against lipid peroxidation in phosphatidylcholine (PC) liposomes as a model membrane. The oxidative process was initiated by peroxyl radicals generated at different sites in liposomes by thermal decomposition of azocompounds. 5-ASA interacts additively with ASC in the protection of membranes against peroxyl radicals generated in the aqueous phase, as evaluated by the oxygen consumption or formation of conjugated dienes. HPLC analysis of 5-ASA indicates that this drug is consumed at a constant rate throughout the oxidation reaction, but in the presence of ASC there is a lag phase of its consumption, denoting that ASC affords an efficient protection to 5-ASA. On the other hand, 5-ASA and ASC cooperate, in an additive way, in the protection of [alpha]-T. When the oxidation starts within the membrane, [alpha]-T is the preferential target of peroxyl radicals, but 5-ASA and ASC also interact additively in sparing of [alpha]-T, increasing not only the inhibition period of oxidation reaction, but also decreasing significantly the rate of [alpha]-T consumption.
id RCAP_e8607193f69a954b55b7aef2891de736
oai_identifier_str oai:estudogeral.uc.pt:10316/5823
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E5-Aminosalicylic acidVitamin CVitamin EInflammatory bowel diseaseAntioxidant activityIt is now recognized that the antioxidant defences in the colonic mucosa from patients with inflammatory bowel disease (IBD) are particularly low. On account of this we studied the antioxidant capacity of 5-ASA, the first choice therapy in this pathological situation, in combination with the endogenous antioxidants vitamins C (ASC) and E ([alpha]-tocopherol ([alpha]-T)) against lipid peroxidation in phosphatidylcholine (PC) liposomes as a model membrane. The oxidative process was initiated by peroxyl radicals generated at different sites in liposomes by thermal decomposition of azocompounds. 5-ASA interacts additively with ASC in the protection of membranes against peroxyl radicals generated in the aqueous phase, as evaluated by the oxygen consumption or formation of conjugated dienes. HPLC analysis of 5-ASA indicates that this drug is consumed at a constant rate throughout the oxidation reaction, but in the presence of ASC there is a lag phase of its consumption, denoting that ASC affords an efficient protection to 5-ASA. On the other hand, 5-ASA and ASC cooperate, in an additive way, in the protection of [alpha]-T. When the oxidation starts within the membrane, [alpha]-T is the preferential target of peroxyl radicals, but 5-ASA and ASC also interact additively in sparing of [alpha]-T, increasing not only the inhibition period of oxidation reaction, but also decreasing significantly the rate of [alpha]-T consumption.http://www.sciencedirect.com/science/article/B6T7W-3TTCHKK-P/1/a981a1607f10aa4509de6e4827b49c131998info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleaplication/PDFhttp://hdl.handle.net/10316/5823http://hdl.handle.net/10316/5823https://doi.org/10.1016/S0378-5173(98)00211-7engInternational Journal of Pharmaceutics. 172:1-2 (1998) 219-228Gonçalves, ElisabeteAlmeida, Leonor M.Dinis, Teresa C. P.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2020-11-06T16:59:50Zoai:estudogeral.uc.pt:10316/5823Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:47:19.273916Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
title Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
spellingShingle Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
Gonçalves, Elisabete
5-Aminosalicylic acid
Vitamin C
Vitamin E
Inflammatory bowel disease
Antioxidant activity
title_short Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
title_full Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
title_fullStr Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
title_full_unstemmed Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
title_sort Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E
author Gonçalves, Elisabete
author_facet Gonçalves, Elisabete
Almeida, Leonor M.
Dinis, Teresa C. P.
author_role author
author2 Almeida, Leonor M.
Dinis, Teresa C. P.
author2_role author
author
dc.contributor.author.fl_str_mv Gonçalves, Elisabete
Almeida, Leonor M.
Dinis, Teresa C. P.
dc.subject.por.fl_str_mv 5-Aminosalicylic acid
Vitamin C
Vitamin E
Inflammatory bowel disease
Antioxidant activity
topic 5-Aminosalicylic acid
Vitamin C
Vitamin E
Inflammatory bowel disease
Antioxidant activity
description It is now recognized that the antioxidant defences in the colonic mucosa from patients with inflammatory bowel disease (IBD) are particularly low. On account of this we studied the antioxidant capacity of 5-ASA, the first choice therapy in this pathological situation, in combination with the endogenous antioxidants vitamins C (ASC) and E ([alpha]-tocopherol ([alpha]-T)) against lipid peroxidation in phosphatidylcholine (PC) liposomes as a model membrane. The oxidative process was initiated by peroxyl radicals generated at different sites in liposomes by thermal decomposition of azocompounds. 5-ASA interacts additively with ASC in the protection of membranes against peroxyl radicals generated in the aqueous phase, as evaluated by the oxygen consumption or formation of conjugated dienes. HPLC analysis of 5-ASA indicates that this drug is consumed at a constant rate throughout the oxidation reaction, but in the presence of ASC there is a lag phase of its consumption, denoting that ASC affords an efficient protection to 5-ASA. On the other hand, 5-ASA and ASC cooperate, in an additive way, in the protection of [alpha]-T. When the oxidation starts within the membrane, [alpha]-T is the preferential target of peroxyl radicals, but 5-ASA and ASC also interact additively in sparing of [alpha]-T, increasing not only the inhibition period of oxidation reaction, but also decreasing significantly the rate of [alpha]-T consumption.
publishDate 1998
dc.date.none.fl_str_mv 1998
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/5823
http://hdl.handle.net/10316/5823
https://doi.org/10.1016/S0378-5173(98)00211-7
url http://hdl.handle.net/10316/5823
https://doi.org/10.1016/S0378-5173(98)00211-7
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv International Journal of Pharmaceutics. 172:1-2 (1998) 219-228
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv aplication/PDF
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133750569730048